Company Search:
Advanced Search
Sponsored Links
Remedis SA Company Snapshot
Remedis SA operates in the Misc. business credit institutions sector. In addition to historical fundamental analyses, the complete report available to purchase compares Remedis SA with three other financial institutions in Europe: Tiger Royalties and Investments PLCTig er Royalties and Investments PLC of UNITED KINGDOM (2019 sales of £155,107.00 [US$201,176.88 ] ), Murphy & Spitz Green Capital AG of GERMANY (174,775.43 Euros [US$206,589.80 ] ), and INVL Technology SUTPKIB which is based in LITHUANIA (185,000.00 Euros [US$218,675.55 ] of which 100% was Investments in information technology bu).

Sales Analysis. Remedis SA reported sales of 768,725.23 Polish New Zlotys (US$204.12 thousand) for the year ending December of 2019. This represents an increase of 53.7% versus 2018, when the company's sales were 500,109.49 Polish New Zlotys. Despite this increase, sales are still well below the level achieved in 2017, when Remedis SA reported sales of 947,051.28 Polish New Zlotys.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Remedis SA
  Stock Performance Chart for Remedis SA
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): .11
(Figures in Polish New Zlotys)
1 Week -1.8%   13 Weeks -28.0%  
4 Weeks 80.0%   52 Weeks 191.9%  
Remedis SA Key Data:
  Ticker: REM Country: Poland
  Exchanges: WAR Major Industry: Diversified Financials
    Sub Industry: Misc. Business Credit Institutions
  2019 Sales 768,725
(Year Ending Jan 2020).
Employees: 2
  Currency: Polish New Zlotys Market Cap: 6,836,411
  Fiscal Yr Ends: December Shares Outstanding: 63,300,102
  Share Type: Akcje Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.